Xuena Wang Selected Research

romiplostim

1/2017	Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.
6/2016	Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia.
5/2016	Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim.
12/2015	Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.
9/2015	Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.
11/2013	Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
5/2012	Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
1/2011	Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP).
11/2010	Romiplostim or standard of care in patients with immune thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuena Wang Research Topics

Disease

10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2018 - 11/2010
6	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2019
5	Hemorrhage 08/2018 - 11/2010
4	Neoplasms (Cancer) 12/2021 - 04/2006
4	Hyperuricemia 10/2021 - 01/2020
3	Inflammation (Inflammations) 10/2021 - 11/2019
3	Thrombosis (Thrombus) 01/2017 - 11/2013
2	Hypertension (High Blood Pressure) 01/2022 - 12/2021
2	Body Weight (Weight, Body) 12/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 06/2016 - 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Hypothyroidism 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Hypertrophy 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Obesity 01/2021
1	Sarcopenia 01/2021
1	Overweight 01/2021
1	Insulin Resistance 12/2020
1	Dyslipidemias (Dyslipidemia) 10/2020
1	Glucose Intolerance 03/2020
1	Prediabetic State (Prediabetes) 03/2020
1	Breast Diseases (Breast Disease) 01/2020
1	Sepsis (Septicemia) 05/2018
1	Pulmonary Hypertension 01/2017
1	Infections 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2015

Drug/Important Bio-Agent (IBA)

9	romiplostim FDA Link 01/2017 - 11/2010
8	Inosine Triphosphate (ITP)IBA 08/2018 - 01/2011
4	Thyroid HormonesIBA 01/2022 - 10/2020
3	ORALIT (ORS)IBA 01/2022 - 12/2020
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022 - 04/2021
3	Uric Acid (Urate)IBA 10/2021 - 01/2020
3	Thrombopoietin ReceptorsIBA 01/2017 - 11/2013
2	LipidsIBA 01/2022 - 10/2020
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 04/2021
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022 - 04/2021
2	SugarsIBA 10/2021 - 01/2020
2	AntioxidantsIBA 01/2021 - 12/2020
2	Thrombopoietin (c-mpl Ligand)IBA 05/2016 - 11/2010
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AlbuminsIBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	IodineIBA 12/2021
1	PalmitatesIBA 12/2021
1	ProdrugsIBA 12/2021
1	Xanthine OxidaseIBA 10/2021
1	Fatty AlcoholsIBA 01/2021
1	Capsaicin (Zostrix)FDA Link 01/2021
1	capsiateIBA 01/2021
1	Soybean Proteins (Soy Protein)IBA 12/2020
1	IsoflavonesIBA 12/2020
1	HDL CholesterolIBA 10/2020
1	oxidized low density lipoproteinIBA 10/2020
1	CholesterolIBA 10/2020
1	LDL CholesterolIBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 03/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	TeaIBA 11/2019
1	hydroxide ionIBA 01/2019
1	cisatracurium (Nimbex)FDA Link 05/2018
1	eltrombopag FDA Link 01/2018
1	Reticulin (Reticular Fiber)IBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 04/2006

Therapy/Procedure

3	Splenectomy 01/2017 - 11/2010
1	Renal Dialysis (Hemodialysis) 01/2022
1	Injections 12/2021
1	Intravenous Injections 12/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 08/2018
1	Punctures 05/2018
1	Ligation 05/2018
1	Therapeutics 01/2018
1	Withholding Treatment 05/2016
1	Blood Transfusion (Blood Transfusions) 11/2010
1	Subcutaneous Injections 11/2010